Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent …
1 month ago
vumedi.com
Dr. Brammer on Brentuximab Vedotin for Patients With T-Cell Lymphoma | OncLive
Dr. Brammer on Brentuximab Vedotin for Patients With T-Cell Ly…
Oct 26, 2017
onclive.com
Erdafitinib versus enfortumab vedotin in previously treated urothelial carcinoma | Urology Times
Erdafitinib versus enfortumab vedotin in previously treated uroth…
Apr 6, 2021
urologytimes.com
Improved OS With 1L Brentuximab Vedotin Chemo in Stage III/IV Classical Hodgkin Lymphoma: 6-Year Analysis of ECHELON-1
Improved OS With 1L Brentuximab Vedotin Chemo in Stage III/IV Clas…
Jul 26, 2022
vumedi.com
Up to 40% of patients receiving the standard R-CHOP regimen for diffuse large B-cell lymphoma have refractory disease or relapse. A modified regimen might improve outcomes. New research findings are summarized in a short video. https://nej.md/3rSJ41d | The New England Journal of Medicine
2:12
Up to 40% of patients receiving the standard R-CHOP regimen for diff…
5.6K viewsJan 27, 2022
FacebookThe New England Journal of Medicine
A combination of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine has been shown to improve progression-free survival in Hodgkin's lymphoma. Data on overall survival are needed. New research findings are summarized in a short video. https://nej.md/3BciZAQ | The New England Journal of Medicine
2:15
A combination of brentuximab vedotin plus doxorubicin, vinblast…
3.7K viewsJul 27, 2022
FacebookThe New England Journal of Medicine
For patients with recurrent cervical cancer, limited treatment options are available. Whether the antibody–drug conjugate tisotumab vedotin improves overall survival is unknown. Research findings are summarized in a new Quick Take video. https://nej.md/4btNAZ9 | The New England Journal of Medicine
2:13
For patients with recurrent cervical cancer, limited treatment options …
969 viewsJul 9, 2024
FacebookThe New England Journal of Medicine
2:16
In high-risk Hodgkin’s lymphoma, brentuximab vedotin in combinati…
1.6K viewsOct 31, 2022
FacebookThe New England Journal of Medicine
Dr Goldman on the Efficacy of Telisotuzumab Vedotin in Advanc…
11 months ago
onclive.com
Disitamab Vedotin: Promising HER2-Targeted Therapy for Uroth…
Sep 15, 2024
urotoday.com
Disitamab Vedotin: Promising HER2-Targeted Therapy for Uroth…
Sep 15, 2024
urotoday.com
4:34
Enfortumab vedotin and pembrolizumab improves EFS, OS…
2 weeks ago
YouTubeecancer
ECHELON-1 Trial: Brentuximab Vedotin With Chemotherapy Offer…
Aug 8, 2022
ascopost.com
1:39
Pembrolizumab/Lenvatinib Combo Achieves Promising Responses i…
1.2K viewsSep 19, 2020
YouTubeTargeted Oncology
2:39
Enfortumab Vedotin Approved by FDA for Patients With Refractory …
388 viewsJan 10, 2020
YouTubeGrand Rounds in Urology
8:07
Long term outcome of enfortumab vedotin + pembrolizumab in first li…
907 viewsAug 3, 2021
YouTubeecancer
1:25
Dr. Brammer on Brentuximab Vedotin for Patients With T-Cell Ly…
303 viewsOct 26, 2017
YouTubeOncLive
1:19
Dr. Smith Discusses Brentuximab Vedotin in CTCL
367 viewsJul 20, 2018
YouTubeOncLive
6:13
Brentuximab Vedotin
2.8K viewsSep 14, 2016
YouTubeOncLive
2:30
Brentuximab vedotin for CTCL
252 viewsOct 15, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:38
Brentuximab Vedotin Overview and Treatment Advice
2.8K viewsJan 28, 2019
YouTubeOncLive
5:16
Drug Development: Brentuximab Vedotin
1.5K viewsMar 24, 2022
YouTubeCutaneousLymphomaFnd
1:47
Dr. Hamlin Discusses Integrating Brentuximab Vedotin
827 viewsFeb 10, 2012
YouTubeOncLive
59:12
Latest Advances in Bladder Cancer Treatment
1.7K viewsDec 11, 2024
YouTubeBladder Cancer Canada
1:00
Rash management for Enfortumab Vedotin
791 viewsApr 21, 2024
YouTubeOncBrothers: Practice-Changing Cancer Discus…
5:46
Glofitamab and polatuzumab vedotin in DLBCL
811 viewsFeb 2, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:57
Potential for Glembatumumab Vedotin in TNBC
329 viewsDec 9, 2016
YouTubeTargeted Oncology
2:11
Dr. Zelenetz Discusses CD30 as a Target in Lymphoma
383 viewsDec 18, 2012
YouTubeTargeted Oncology
2:23
Enfortumab Vedotin–Pembrolizumab in Advan…
5K viewsMar 7, 2024
YouTubeNEJM Group
6:57
Brentuximab Vedotin in CD30-Positive Lymphoma
2.7K viewsMar 12, 2014
YouTubeOncLive
See more videos
Static thumbnail place holder